Financhill
Sell
40

INMB Quote, Financials, Valuation and Earnings

Last price:
$2.05
Seasonality move :
-28%
Day range:
$1.81 - $1.92
52-week range:
$1.38 - $11.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
904.01x
P/B ratio:
2.00x
Volume:
446.4K
Avg. volume:
398.7K
1-year change:
-60.78%
Market cap:
$50.8M
Revenue:
$14K
EPS (TTM):
-$2.14

Earnings Data

Next earnings date for INMB
Mar 31
2026
Most recent earnings per share
-$0.24
Beat by $0.08
(Oct 30/2025)
Consensus Estimate
-$0.33
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INMB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q4 -- -- -- -$0.26 --
10/30/2025 Q3 -- -- -$0.24 -$0.33 $0.08
08/07/2025 Q2 -- -- -$1.05 -$0.38 -$0.67
05/08/2025 Q1 -- $50K -$0.43 -$0.46 $0.02
03/27/2025 Q4 -- -- -$0.41 -$0.53 $0.12
10/31/2024 Q3 -- -- -$0.60 -$0.49 -$0.11
08/01/2024 Q2 $4.7K -- -$0.50 -$0.62 $0.12
05/09/2024 Q1 $14K $14K -$0.61 -$0.52 -$0.09
03/28/2024 Q4 $14.3K $28K -$0.47 -$0.47 -$0.00
11/01/2023 Q3 -- -- -$0.48 -$0.40 -$0.08
08/07/2023 Q2 -- -- -$0.36 -$0.39 $0.03
05/03/2023 Q1 -- -- -$0.36 -- --
03/02/2023 Q4 -- -- -$0.32 -$0.50 $0.18
11/02/2022 Q3 -- -- -$0.43 -$0.53 $0.10
08/03/2022 Q2 -- -- -$0.38 -$0.48 $0.10
05/05/2022 Q1 -- -- -$0.39 -$0.60 $0.21
03/03/2022 Q4 -- -- -$0.55 -$0.55 --
11/03/2021 Q3 -- -- -$0.55 -$0.41 -$0.15
08/04/2021 Q2 -- -- -$0.44 -$0.34 -$0.10
05/05/2021 Q1 -- -- -$0.32 -$0.28 -$0.05
03/04/2021 Q4 -- -- -$0.24 -$0.28 $0.04
11/05/2020 Q3 -- -- -$0.36 -$0.17 -$0.19
08/05/2020 Q2 -- -- -$0.20 -$0.23 $0.03
05/14/2020 Q1 -- -- -$0.19 -$0.21 $0.02
03/11/2020 Q4 -- -- -$0.22 -$0.25 $0.03
11/08/2019 Q3 -- -- -$0.28 -$0.19 -$0.09
08/12/2019 Q2 -- -- -$0.04 -$0.20 $0.16
05/15/2019 Q1 -- -- -$0.20 -$0.19 -$0.01
12/31/2018 Q4 -- -- -$0.17 -$0.19 $0.02
09/30/2018 Q3 -- -- -$0.14 -- --
06/30/2018 Q2 -- -- -$0.55 -- --
03/31/2018 Q1 -- -- -$0.25 -- --
12/31/2017 Q4 -- -- -$0.04 -- --
09/30/2017 Q3 -- -- -$0.03 -- --

INmune Bio, Inc. Earnings Questions

  • How Much did INmune Bio, Inc. Generate in Revenue Last Quarter?

    INmune Bio, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did INmune Bio, Inc. Beat Earnings Last Quarter?

    INmune Bio, Inc. announced earnings per share of -$0.24 which represents a beat of analyst forecast a -$0.33 per share.

  • Is INmune Bio, Inc. Profitable?

    INmune Bio, Inc. reported -$28K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for INmune Bio, Inc. EPS Next Year?

    INmune Bio, Inc.'s earnings are forecast to decrease from -$2.11 per share to -$2.24 per share next year representing a decrease of -34.12%.

  • When is INmune Bio, Inc.'s Earnings Date?

    INmune Bio, Inc.'s next earnings date is March 31, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 5.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock